A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia

NCT07687784 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1366

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia (IDA)

Interventions

DRUG: Ferric Bepectate IV Injection
DRUG: Ferric Carboxymaltose Injection [Ferinject]
DRUG: Ferric Carboxymaltose Injection [Injectafer®]

Sponsor

AFT Pharmaceuticals, Ltd.

Collaborators

[object Object]